Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of anti-IgE treatment will
make peanut oral immunotherapy safer, more tolerable, and more effective in treating peanut
allergy.